This product is for research use only, not for human use. We do not sell to patients.
Size | Price | Stock |
---|---|---|
100mg | $2025 | Check With Us |
200mg | $3035 | Check With Us |
500mg | $5120 | Check With Us |
Cat #: V4794 CAS #: 1715025-32-3 Purity ≥ 98%
Description: Rineterkib (LTT-462; ERK-IN-1; ERK-IN1), the compound B extracted from WO2018051306A1, is a novel and potent RAF and ERK1/2 inhibitor with anticancer activity.
References: CAPONIGRO, et al. THERAPEUTIC COMBINATIONS COMPRISING A RAF INHIBITOR AND A ERK INHIBITOR. WO2018051306A1.
Publications Citing InvivoChem Products
Product Promise
- Physicochemical and Storage Information
- Protocol
- Related Biological Data
- Stock Solution Preparation
- Quality Control Documentation
Molecular Weight (MW) | 578.42 |
---|---|
Molecular Formula | C₂₆H₂₇BrF₃N₅O₂ |
CAS No. | 1715025-32-3 |
Storage | -20℃ for 3 years in powder formr |
-80℃ for 2 years in solvent | |
SMILES Code | O=C(N[C@@H](C1=CC(F)=CC(Br)=C1)CNC)C2=CC=C(C3=NC([C@@H]4C[C@H](F)[C@@H](O)CC4)=CN=C3N)C=C2F |
Synonyms | LTT 462; LTT-462; LTT462; Rineterkib; ERK-IN-1; ERK IN 1; ERK IN-1; ERK-IN 1; |
Protocol | In Vivo | Rineterkib (compound B) (50, 75 mg/kg, p.o., qd/q2d, 27 days) treatment significantly reduces the tumor volume in the Calu-6 human NSCLC subcutaneous tumor xenograft model in mice. |
---|
Solvent volume to be added | Mass (the weight of a compound) | |||
---|---|---|---|---|
Mother liquor concentration | 1mg | 5mg | 10mg | 20mg |
1mM | 1.7288 mL | 8.6442 mL | 17.2885 mL | 34.5770 mL |
5mM | 0.3458 mL | 1.7288 mL | 3.4577 mL | 6.9154 mL |
10mM | 0.1729 mL | 0.8644 mL | 1.7288 mL | 3.4577 mL |
20mM | 0.0864 mL | 0.4322 mL | 0.8644 mL | 1.7288 mL |
This equation is commonly abbreviated as: C1 V1 = C2 V2
- (1) Please be sure that the solution is clear before the addition of next solvent. Dissolution methods like vortex, ultrasound or warming and heat may be used to aid dissolving.
- (2) Be sure to add the solvent(s) in order.